Alaunos Therapeutics, Inc. (TCRT)

NASDAQ: TCRT · Real-Time Price · USD

Compare

3.300

+0.070 (2.17%)

At close: Jan 2, 2026, 4:00 PM EST

3.280

-0.020 (-0.61%)

After-hours: Jan 2, 2026, 4:00 PM EST

Alaunos Therapeutics Market Cap

Alaunos Therapeutics has a market cap or net worth of $7.37 million as of January 2, 2026. Its market cap has increased by 145.50% in one year.

Market Cap

7.37M

Enterprise Value

5.27M

1-Year Change

145.50%

Ranking

#5246

Market Cap Chart

Since September 22, 2006, Alaunos Therapeutics's market cap has decreased from $76.30M to $7.37M, a decrease of -90.35%. That is a compound annual growth rate of -11.42%.

Market Cap History

Date	Market Cap	% Change
Dec 31, 2025	7.20M	132.26%
Dec 31, 2024	3.10M	-81.76%
Dec 29, 2023	17.00M	-87.88%
Dec 30, 2022	140.30M	-40.45%
Dec 31, 2021	235.60M	-56.37%
Dec 31, 2020	540.00M	-36.81%
Dec 31, 2019	854.50M	220.88%
Dec 31, 2018	266.30M	-54.69%
Dec 29, 2017	587.70M	-16.61%
Dec 30, 2016	704.80M	-35.20%
Dec 31, 2015	1.09B	108.89%
Dec 31, 2014	520.70M	43.36%
Dec 31, 2013	363.20M	9.66%
Dec 31, 2012	331.20M	9.71%
Dec 30, 2011	301.90M	33.41%
Dec 31, 2010	226.30M	198.94%
Dec 31, 2009	75.70M	510.48%
Dec 31, 2008	12.40M	-83.49%
Dec 31, 2007	75.10M	-17.56%
Dec 29, 2006	91.10M	19.40%
Sep 22, 2006	76.30M	-

View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	966.79B
Johnson & Johnson	498.51B
AbbVie	406.04B
UnitedHealth Group	300.88B
AstraZeneca	287.28B
Novartis AG	266.00B
Merck & Co.	263.24B
Novo Nordisk	227.63B

Market Cap Rankings